Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Raboud

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individualsJ M Raboud, L Haley, J S Montaner, et al.
Mathematical Biosciences|April 28, 2001
A computer model to simulate family history of breast/ovarian cancer in BRCA1 mutation carriersC D Bajdik, J M Raboud, M T Schechter, et al.
Infection Control and Hospital Epidemiology|June 30, 2006
Accuracy of healthcare worker recall and medical record review for identifying infectious exposures to hospitalized patientsM Aquino, J M Raboud, A McGeer, et al.
The Journal of Infectious Diseases|July 1, 1996
Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infectionJ M Raboud, J S Montaner, B Conway, et al.
American Journal of Respiratory and Critical Care Medicine|November 11, 1999
Burkholderia cepacia in cystic fibrosis. Variable disease courseD D Frangolias, E Mahenthiralingam, S Rae, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2000
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study teamJ M Raboud, S Rae, S Vella, et al.
The Journal of Infectious Diseases|February 11, 2000
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudineJ S Montaner, T Mo, J M Raboud, et al.
HIV Clinical Trials|April 17, 2007
Virologic and immunologic impact and durability of enfuvirtide-based antiretroviral therapy in HIV-infected treatment-experienced patients in a clinical settingM R Loutfy, T Antoniou, S Shen, et al.
Diabetes, Obesity & Metabolism|August 22, 2006
Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trialB Zinman, S B Harris, H C Gerstein, et al.
Infection Control and Hospital Epidemiology|October 11, 2007
Factors associated with critical-care healthcare workers' adherence to recommended barrier precautions during the Toronto severe acute respiratory syndrome outbreakA Shigayeva, K Green, J M Raboud, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individualsJ M Raboud, L Haley, J S Montaner, et al.
Mathematical Biosciences|April 28, 2001
A computer model to simulate family history of breast/ovarian cancer in BRCA1 mutation carriersC D Bajdik, J M Raboud, M T Schechter, et al.
Infection Control and Hospital Epidemiology|June 30, 2006
Accuracy of healthcare worker recall and medical record review for identifying infectious exposures to hospitalized patientsM Aquino, J M Raboud, A McGeer, et al.
The Journal of Infectious Diseases|July 1, 1996
Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infectionJ M Raboud, J S Montaner, B Conway, et al.
American Journal of Respiratory and Critical Care Medicine|November 11, 1999
Burkholderia cepacia in cystic fibrosis. Variable disease courseD D Frangolias, E Mahenthiralingam, S Rae, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2000
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study teamJ M Raboud, S Rae, S Vella, et al.
The Journal of Infectious Diseases|February 11, 2000
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudineJ S Montaner, T Mo, J M Raboud, et al.
HIV Clinical Trials|April 17, 2007
Virologic and immunologic impact and durability of enfuvirtide-based antiretroviral therapy in HIV-infected treatment-experienced patients in a clinical settingM R Loutfy, T Antoniou, S Shen, et al.
Diabetes, Obesity & Metabolism|August 22, 2006
Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trialB Zinman, S B Harris, H C Gerstein, et al.
Infection Control and Hospital Epidemiology|October 11, 2007
Factors associated with critical-care healthcare workers' adherence to recommended barrier precautions during the Toronto severe acute respiratory syndrome outbreakA Shigayeva, K Green, J M Raboud, et al.
Pageof 4